The Community recognises the utmost desirability of promoting the transfer of technology and capacity-building to countries with insufficient or no manufacturing capacity in the pharmaceutical sector, in order to facilitate and increase the production of pharmaceutical products by those countries.
Recital 13, Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006…
In forcesince 17 May 2006